College of Health and Biomedicine, Institute for Health and Sport, Victoria University, Melbourne, Australia.
Department of Medicine Western Health, Melbourne University, Melbourne, Australia.
Inflamm Bowel Dis. 2019 Jun 18;25(7):1140-1151. doi: 10.1093/ibd/izz024.
Clinical investigations in inflammatory bowel disease (IBD) patients have provided increasing evidence that eosinophils contribute to chronic intestinal inflammation. Accumulation of eosinophils in the gastrointestinal tract correlates with the variations of eosinophil regulatory molecules; however, their role in gastrointestinal dysfunction in IBD has not been fully elucidated. This review will describe the development and characterization of gastrointestinal eosinophils, mechanisms of eosinophil recruitment to the gastrointestinal tract. Moreover, the eosinophil-induced changes to the enteric nervous system associated with disease severity and gastrointestinal dysfunction will be analyzed with suggestive molecular pathways for enteric neuronal injury. Current and potential therapeutic interventions targeting eosinophils will be discussed.
临床研究表明,嗜酸性粒细胞在炎症性肠病(IBD)患者中发挥作用,有助于慢性肠道炎症的发生。胃肠道嗜酸性粒细胞的积累与嗜酸性粒细胞调节分子的变化相关,但它们在 IBD 中的胃肠道功能障碍中的作用尚未完全阐明。本综述将描述胃肠道嗜酸性粒细胞的发展和特征,嗜酸性粒细胞向胃肠道募集的机制。此外,还将分析与疾病严重程度和胃肠道功能障碍相关的嗜酸性粒细胞引起的肠神经变化,并提出肠神经元损伤的潜在分子途径。本文还将讨论针对嗜酸性粒细胞的当前和潜在的治疗干预措施。